Keywords: reprieve, astrazeneca, fda, delays, andrx, generic, omeprazole

Reprieve for AstraZeneca as FDA delays Andrx' generic omeprazole

Article | 05 October 2001

Print This

Just as AstraZeneca's substance patent on its blockbuster antiulcerantPrilosec/Losec (omeprazole) was due to expire in the USA on October 5, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in